These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9853973)

  • 21. Conversion From Once-Daily Prolonged-Release Tacrolimus to Once-Daily Extended-Release Tacrolimus in Stable Liver Transplant Recipients.
    Altieri M; Delaval G; Kimmoun E; Allaire M; Salamé E; Dumortier J
    Exp Clin Transplant; 2018 Jun; 16(3):321-325. PubMed ID: 28697715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results of a phase 4 trial of Tacrobell® in liver transplantation patients: a multicenter study in South Korea.
    Yu YD; Lee SG; Joh JW; Kwon CH; Kim DG; Suh KS; Lee NJ; Hwang S; Ahn CS; Kim KH; Moon DB; Ha TY; Song GW; Jung DH
    Hepatogastroenterology; 2012; 59(114):357-63. PubMed ID: 21940371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Higher Serum Trough Levels of Tacrolimus Increase 5-Year Allograft Survival in Antibody Positive Renal Transplant Patients.
    Peng ZG; Tian J
    Clin Transpl; 2014; ():209-14. PubMed ID: 26281147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative analysis of tacrolimus (FK506) in whole blood liver transplant recipients by PRO-TRAC enzyme-linked immunosorbent assay and microparticle enzyme immunoassay IMX methods.
    Brunet M; Pou L; Torra M; López R; Rodamilans M; Corbella J
    Ther Drug Monit; 1996 Dec; 18(6):706-9. PubMed ID: 8946669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of whole-blood FK506 concentrations to rejection and toxicity in liver and kidney transplants.
    Hedayat S; Kershner RP; Su G
    J Biopharm Stat; 1996 Nov; 6(4):411-24. PubMed ID: 8969977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacoepidemiology of tacrolimus in pediatric liver transplantation.
    Riva N; Schaiquevich P; Cáceres Guido P; Halac E; Dip M; Imventarza O
    Pediatr Transplant; 2017 Aug; 21(5):. PubMed ID: 28574195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical pharmacokinetics of tacrolimus in rescue therapy after renal transplantation.
    Budde K; Fritsche L; Mai I; Bauer S; Smettan S; Waiser J; Hofmann T; Hauser I; Reinke P; Neumayer HH
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):493-7. PubMed ID: 8937932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial.
    Pascual J; del Castillo D; Cabello M; Pallardó L; Grinyó JM; Fernández AM; Brunet M
    Transplantation; 2010 Apr; 89(8):994-1000. PubMed ID: 20335831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of CYP3A5 polymorphism on trough concentrations and outcomes of tacrolimus minimization during the early period after kidney transplantation.
    Yaowakulpatana K; Vadcharavivad S; Ingsathit A; Areepium N; Kantachuvesiri S; Phakdeekitcharoen B; Sukasem C; Sra-Ium S; Sumethkul V; Kitiyakara C
    Eur J Clin Pharmacol; 2016 Mar; 72(3):277-83. PubMed ID: 26635230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tacrolimus trough levels and level-to-dose ratio in stable renal transplant patients converted to a once-daily regimen.
    Meçule A; Tinti F; Poli L; Bachetoni A; Umbro I; Nofroni I; Lai Q; Pretagostini R; Berloco PB; Mitterhofer AP
    Transplant Proc; 2011 May; 43(4):1024-7. PubMed ID: 21620042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tacrolimus blood levels and incidence of graft rejection in heart transplantation].
    Albornoz López R; Aumente Rubio MD; Arizón Del Prado JM; Cárdenas Aranzana M; López Malo de Molina MD; Gago Sánchez AI
    Farm Hosp; 2005; 29(3):158-63. PubMed ID: 16013941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
    Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
    Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial.
    McDiarmid SV; Busuttil RW; Ascher NL; Burdick J; D'Alessandro AM; Esquivel C; Kalayoglu M; Klein AS; Marsh JW; Miller CM
    Transplantation; 1995 Feb; 59(4):530-6. PubMed ID: 7533345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pharmacodynamic investigation of tacrolimus in pediatric liver transplantation.
    Staatz CE; Taylor PJ; Lynch SV; Tett SE
    Liver Transpl; 2004 Apr; 10(4):506-12. PubMed ID: 15048793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Basiliximab in a triple-drug regimen with tacrolimus and steroids in liver transplantation.
    Gruttadauria S; Vasta F; Mandalà L; Cintorino D; Piazza T; Spada M; Verzaro R; Gridelli B
    Transplant Proc; 2005; 37(6):2611-3. PubMed ID: 16182762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients.
    Wallemacq PE; Furlan V; Möller A; Schäfer A; Stadler P; Firdaous I; Taburet AM; Reding R; Clement De Clety S; De Ville De Goyet J; Sokal E; Lykavieris L; Van Leeuw V; Bernard O; Otte JB; Undre NA
    Eur J Drug Metab Pharmacokinet; 1998; 23(3):367-70. PubMed ID: 9842978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral administration of tacrolimus in the presence of jejunostomy after liver transplantation.
    Hasegawa T; Nara K; Kimura T; Soh H; Sasaki T; Azuma T; Okada A
    Pediatr Transplant; 2001 Jun; 5(3):204-9. PubMed ID: 11422824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of CYP3A5 and MDR1 polymorphisms on tacrolimus concentration in the early stage after renal transplantation.
    Zhang X; Liu ZH; Zheng JM; Chen ZH; Tang Z; Chen JS; Li LS
    Clin Transplant; 2005 Oct; 19(5):638-43. PubMed ID: 16146556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term use of FK 506 in living related liver transplantation.
    Uemoto S; Tanaka K; Tokunaga Y; Nishizawa T; Sawada H; Katoh H; Yamamoto E; Yamaoka Y; Ozawa K
    Transpl Int; 1994; 7 Suppl 1():S81-4. PubMed ID: 11271341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients.
    Venkataramanan R; Shaw LM; Sarkozi L; Mullins R; Pirsch J; MacFarlane G; Scheller D; Ersfeld D; Frick M; Fitzsimmons WE; Virji M; Jain A; Brayman KL; Shaked A
    J Clin Pharmacol; 2001 May; 41(5):542-51. PubMed ID: 11361051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.